NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,484,924 | -15.0% | 205,100 | -12.8% | 0.10% | -10.2% |
| Q2 2023 | $1,747,536 | +236.2% | 235,200 | +213.6% | 0.11% | +217.6% |
| Q1 2023 | $519,750 | -67.6% | 75,000 | -51.9% | 0.03% | -62.6% |
| Q4 2022 | $1,603,680 | +9.0% | 156,000 | +92.8% | 0.09% | +31.9% |
| Q3 2022 | $1,471,000 | -79.2% | 80,900 | -41.2% | 0.07% | -76.0% |
| Q2 2022 | $7,072,000 | +48.4% | 137,524 | +112.6% | 0.29% | +66.5% |
| Q1 2022 | $4,765,000 | -71.6% | 64,700 | -44.7% | 0.17% | -71.0% |
| Q4 2021 | $16,750,000 | -40.8% | 117,078 | -14.2% | 0.60% | -50.5% |
| Q3 2021 | $28,302,000 | -10.4% | 136,520 | -8.3% | 1.20% | -8.0% |
| Q2 2021 | $31,591,000 | +3.1% | 148,800 | -11.9% | 1.31% | +3.7% |
| Q1 2021 | $30,634,000 | +49.5% | 168,964 | -8.0% | 1.26% | +60.4% |
| Q4 2020 | $20,486,000 | +28.7% | 183,700 | +25.0% | 0.79% | +4.4% |
| Q3 2020 | $15,919,000 | +89.6% | 146,921 | +45.9% | 0.75% | +58.5% |
| Q2 2020 | $8,394,000 | – | 100,700 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,758,833 | $396,649,000 | 7.73% |
| TSP Capital Management Group, LLC | 72,575 | $6,049,000 | 2.58% |
| Beirne Wealth Consulting Services, LLC | 22,250 | $1,855,000 | 1.51% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 93,000 | $7,752,000 | 1.41% |
| Rock Springs Capital Management LP | 570,598 | $47,559,000 | 1.30% |
| Sargent Investment Group, LLC | 38,059 | $3,033,000 | 1.14% |
| Harvest Investment Services, LLC | 19,580 | $1,631,000 | 0.97% |
| Parkman Healthcare Partners LLC | 40,000 | $3,334,000 | 0.94% |
| EAM Investors, LLC | 39,055 | $3,255,000 | 0.72% |
| EAM Global Investors LLC | 17,774 | $1,481,000 | 0.67% |